drugset / Trial / NCT00891332
Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a multicenter study designed to evaluate the response rate of S-1 plus Leucovorin (1 week on and 1 week off) as first -line treatment for patients with metastatic colorectal cancer.
Timeline
- Start
- 2008-10
- Primary completion
- 2011-07
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leucovorin | Small molecule | 25 mg | — |
| Subject | S-1 | Small molecule | 40 mg | — |
| Subject | S-1 | Small molecule | 60 mg | — |